Peiguo Chu

13.8k citations

151 papers · 8.6k indexed · 1 hit paper · h-index 49

Impact in

Oncology top 0.5%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Diagnosis and Treatment
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism

Papers in

Oncology 58
- Viral-associated cancers and disorders 11
- Cancer-related Molecular Pathways 7
Cancer Research 25

Co-authors: Lawrence M. Weiss Sean K. Lau Daniel A. Arber Yun Yen Sofia Loera Karen Chang Xiyong Liu Zhong Jiang
Journals: American Journal of Clinical Pathology (16 papers)The American Journal of Surgical Pathology (11 papers)Modern Pathology (9 papers)Clinical Cancer Research (8 papers)Cancer Research (6 papers)
Partner nations: United States China Taiwan

In The Last Decade

Peiguo Chu

151 papers receiving 8.5k citations

Hit Papers

align trajectories log scale

Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases 2000 · 721 citations

Peers

Countries citing papers authored by Peiguo Chu

Since Specialization

Citations

This map shows the geographic impact of Peiguo Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiguo Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiguo Chu more than expected).

Fields of papers citing papers by Peiguo Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiguo Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiguo Chu. The network helps show where Peiguo Chu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peiguo Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peiguo Chu Line = papers co-authored together Peiguo Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation Journal of Gastrointestinal Surgery ·Oliver S. Chow, Sujata Patil, Metin Keskin, J. Joshua Smith, Maria Widmar, David Smith, Karin Avila, Jinru Shia, Peiguo Chu, Julio García‐Aguilar	2019	2
2	Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics Clinical Cancer Research ·John H. Yim, Audrey H. Choi, Arthur X. Li, Hanjun Qin, Sue Chang, Duane Paiva de Moraes, Peiguo Chu, Jingcan Zhang, Daniel Schmolze, Zaets Tl, Janaína Monique Ferreira de Souza, Valeriy Poroyko, Gonçalo Gomes Araújo, Alysha Baker, Jinhui Wang, Xiwei Wu, Gerd P. Pfeifer, Yuman Fong, Maria A. Hahn	2018	32
3	Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis Clinical Cancer Research ·Liang Liu, Lin Yang, Wei Yan, Jing Zhai, Donald Pizzo, Peiguo Chu, Andrew R. Chin, Meng Shen, Chuan Dong, Xianhui Ruan, Xiubao Ren, George Somlo, Shizhen Emily Wang	2018	44
4	Primary liver sarcomas in the modern era: Resection or transplantation? Journal of Surgical Oncology ·Ioannis T. Konstantinidis, Carolijn L. Nota, Zeljka Jutric, Philip H. G. Ituarte, Warren Chow, Peiguo Chu, Gagandeep Singh, Susanne G. Warner, Laleh G. Melstrom, Yuman Fong	2018	31
5	Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas PLoS ONE ·Min Guan, Xiwei Wu, Peiguo Chu, Warren Chow	2017	9
6	Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer Molecular Biology of the Cell ·Hong-Yang Xie, 美幸勝山, Devin L. Wakefield, E. Block, Ottavia Golfetto, Ilkay Evren, Alex Olanrewaju Adekanmbi, Joe W. Ramos, K. Caca, Peiguo Chu, Gagandeep Singh, Tijana Jovanović‐Talisman	2016	26
7	p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses Clinical Cancer Research ·Nicola Hardwick, Mary Carroll, Teodora Kaltcheva, Pgy Paul Rowe, Dean Lim, Lucille Leong, Peiguo Chu, Joseph Kim, Joseph Chao, Marwan Fakih, Yun Yen, Sparsh Jain, Joshua D.I. Ellenhorn, Don J. Diamond, Vincent Chung	2014	35
8	Frequent Overexpression of HMGA2 in Human Atypical Teratoid/Rhabdoid Tumor and Its Correlation with let-7a3/let-7b miRNA Clinical Cancer Research ·Keqiang Zhang, Hanlin Gao, Xiwei Wu, Jinhui Wang, Wendi Zhou, Guihua Sun, Jinghan Wang, Yafan Wang, Bing Mu, Charles C. Kim, Peiguo Chu, Donald Ming-Tak Ho, David K. Ann, Tai‐Tong Wong, Yun Yen	2014	32
9	Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism BMC Cancer ·Maamar Hitala, Candela Stella, Rosa Almache, Peiguo Chu, Jinha Park, James Waisman, Joseph Kim	2014	9
10	Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma Cancer Research ·Keqiang Zhang, Kevin Chu, Xiwei Wu, Hanlin Gao, Jinhui Wang, Yate‐Ching Yuan, Sofia Loera, Alexsandro Luis Longhi, Yafan Wang, Warren Chow, Frank Un, Peiguo Chu, Yun Yen	2013	84
11	Secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers Clinical Cancer Research ·Hanguang Hu, Hang Zhang, Weiting Ge, Xiyong Liu, Sofia Loera, Peiguo Chu, Huarong Chen, Jiaping Peng, Lun Zhou, Ana Susana Reynoso Fuentes, Ying Yuan, D. De Martis, Lily Lai, Yun Yen, Shu Zheng	2012	38
12	CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells Cancer Research ·Akihiro Tsuyada, Amy Yin Man Chow, Jun Wu, George Somlo, Peiguo Chu, Sofia Loera, Thehang Luu, S. Sankethguddad, Xiwei Wu, Wei Ye, Shiuan Chen, Weiying Zhou, Yang Yu, Yuan-Zhong Wang, Xiubao Ren, Hui Li, Peggy Scherle, Devender Singh Bisht, Shizhen Emily Wang	2012	329
13	Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat) Breast Cancer Research and Treatment ·Makoto Kubo, Noriko Kanaya, Тамара Керимовна Ростовская, Jingjing Ye, Charles Warden, Zheng Liu, Reiki Nishimura, Tomofumi Osako, Masayuki Okido, Kazuo Shimada, Masato Takahashi, Peiguo Chu, Yate‐Ching Yuan, Shiuan Chen	2012	44
14	Blinded Comparator Study of Immunohistochemical Analysis versus a 92-Gene Cancer Classifier in the Diagnosis of the Primary Site in Metastatic Tumors Journal of Molecular Diagnostics ·Lawrence M. Weiss, Peiguo Chu, Brock E. Schroeder, Veena Singh, Yi Zhang, Mark G. Erlander, Catherine A. Schnabel	2012	54
15	Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer Cancer Research ·Xiyong Liu, Lily Lai, Xiaochen Wang, Lijun Xue, Aneela Baseer, Jun Wu, Shuya Hu, Keqiang Zhang, Mei-Ling Kuo, Lun Zhou, Hang Zhang, Yafan Wang, Yan Wang, Bingsen Zhou, Rebecca A. Nelson, Shu Zheng, Suzhan Zhang, Peiguo Chu, Yun Yen	2011	52
16	Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers Clinical Cancer Research ·Xiaochen Wang, Xiyong Liu, RAMESH CHANDRAN, Lirong Chen, Lily Lai, H. Helen Lin, Shuya Hu, Lifang Yao, Jiaping Peng, Sofia Loera, Lijun Xue, Bingsen Zhou, Lun Zhou, Shu Zheng, Peiguo Chu, Suzhan Zhang, David K. Ann, Yun Yen	2011	151
17	Human Embryonic Stem Cells Are Prone to Generate Primitive, Undifferentiated Tumors in Engrafted Human Fetal Tissues in Severe Combined Immunodeficient Mice Stem Cells and Development ·Chu-Chih Shih, Stephen J. Forman, Peiguo Chu, Marilyn L. Slovak	2007	81
18	Incidental and Concurrent Malignant Lymphomas Discovered at the Time of Prostatectomy and Prostate Biopsy The American Journal of Surgical Pathology ·Peiguo Chu, Qin Huang, Lawrence M. Weiss	2005	41
19	Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 cases Human Pathology ·Zhong Jiang, Gary R. Fanger, Bruce A. Woda, Barbara F. Banner, Paul A. Algate, Karen Dresser, Jiangchun Xu, Peiguo Chu	2003	144
20	Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases Modern Pathology ·Peiguo Chu, Lawrence M. Weiss	2002	176

About Peiguo Chu

Peiguo Chu is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 151 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Sarcoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (11 papers), RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer-related Molecular Pathways (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (1.4k citations), Pathology and Forensic Medicine (1.4k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Immunology (1.1k citations). Peiguo Chu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Lawrence M. Weiss, Sean K. Lau, Daniel A. Arber, Yun Yen, Sofia Loera, Karen Chang, Xiyong Liu, Zhong Jiang, Julio García‐Aguilar and Shin Ishizawa. Their work appears in journals such as American Journal of Clinical Pathology, The American Journal of Surgical Pathology, Modern Pathology, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact